NO961543D0 - Antistoff mot aminoterminalt propeptid av type 1 prokollagen og målemetode hvor det benyttes - Google Patents

Antistoff mot aminoterminalt propeptid av type 1 prokollagen og målemetode hvor det benyttes

Info

Publication number
NO961543D0
NO961543D0 NO961543A NO961543A NO961543D0 NO 961543 D0 NO961543 D0 NO 961543D0 NO 961543 A NO961543 A NO 961543A NO 961543 A NO961543 A NO 961543A NO 961543 D0 NO961543 D0 NO 961543D0
Authority
NO
Norway
Prior art keywords
procollagen
type
propeptide
alpha
intact
Prior art date
Application number
NO961543A
Other languages
English (en)
Other versions
NO320120B1 (no
NO961543L (no
Inventor
Juha Risteli
Leila Risteli
Jukka Melkko
Saila Kauppil
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO961543D0 publication Critical patent/NO961543D0/no
Publication of NO961543L publication Critical patent/NO961543L/no
Publication of NO320120B1 publication Critical patent/NO320120B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
NO19961543A 1995-04-19 1996-04-18 Isolert intakt aminoterminalt propeptid av type 1 prokollagen, fremgangsmate for fremstilling derav, antistoff spesifikt for nevnte propeptid, fremgangsmate for analyse av nevnte propeptid, og analysetestsett som omfatter antistoffet og fremgangsmate for separasjon av to former av propeptid. NO320120B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9507985.1A GB9507985D0 (en) 1995-04-19 1995-04-19 Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it

Publications (3)

Publication Number Publication Date
NO961543D0 true NO961543D0 (no) 1996-04-18
NO961543L NO961543L (no) 1996-10-21
NO320120B1 NO320120B1 (no) 2005-10-31

Family

ID=10773218

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961543A NO320120B1 (no) 1995-04-19 1996-04-18 Isolert intakt aminoterminalt propeptid av type 1 prokollagen, fremgangsmate for fremstilling derav, antistoff spesifikt for nevnte propeptid, fremgangsmate for analyse av nevnte propeptid, og analysetestsett som omfatter antistoffet og fremgangsmate for separasjon av to former av propeptid.

Country Status (11)

Country Link
US (3) US5895746A (no)
EP (1) EP0738735B1 (no)
JP (1) JP3245052B2 (no)
AT (1) ATE250084T1 (no)
AU (1) AU707232B2 (no)
CA (1) CA2174559C (no)
DE (1) DE69629976T2 (no)
DK (1) DK0738735T3 (no)
ES (1) ES2207665T3 (no)
GB (1) GB9507985D0 (no)
NO (1) NO320120B1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087318A1 (en) * 1994-04-18 2003-05-08 Lallone Roger L. Antibodies against an extracellular matrix complex and their use in the detection of cancer
US20030082179A1 (en) * 2001-07-03 2003-05-01 Hutchison James Scott Parathyroid hormone antibodies and related methods
CN102690347B (zh) * 2012-05-18 2014-06-25 北京北方生物技术研究所 分离i型前胶原氨基末端肽的方法
EP3866831A4 (en) * 2018-10-16 2022-08-24 Board of Regents, The University of Texas System IDENTIFICATION AND TARGETING OF PATHOGENIC EXTRACELLULAR MATRIX FOR DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES
JP2022505032A (ja) * 2018-10-16 2022-01-14 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム 腫瘍オルガノイドを産生するための組成物および腫瘍オルガノイドを産生する方法
CN111007269A (zh) * 2019-11-15 2020-04-14 迪瑞医疗科技股份有限公司 总ⅰ型胶原氨基端延长肽化学发光免疫检测试剂盒及其制备方法
CN112326972A (zh) * 2020-10-30 2021-02-05 安徽理工大学 一种检测血清中完整pinp的化学发光定量检测试剂盒
WO2023182353A1 (ja) * 2022-03-25 2023-09-28 積水メディカル株式会社 免疫学的検出方法及び免疫学的検出キット
WO2023182343A1 (ja) * 2022-03-25 2023-09-28 積水メディカル株式会社 免疫学的検出方法及び免疫学的検出キット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208865B (en) * 1987-08-19 1991-12-11 Farmos Group Ltd Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody.
GB9014220D0 (en) * 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
ATE161543T1 (de) * 1992-01-31 1998-01-15 David Jeston Baylink Aminoterminale prokollagen 1(i) peptide

Also Published As

Publication number Publication date
DK0738735T3 (da) 2003-12-29
AU5069596A (en) 1996-10-31
DE69629976D1 (de) 2003-10-23
JP3245052B2 (ja) 2002-01-07
AU707232B2 (en) 1999-07-08
EP0738735B1 (en) 2003-09-17
CA2174559A1 (en) 1996-10-20
EP0738735A3 (en) 1999-01-20
US6093803A (en) 2000-07-25
ES2207665T3 (es) 2004-06-01
ATE250084T1 (de) 2003-10-15
CA2174559C (en) 2010-10-19
NO320120B1 (no) 2005-10-31
DE69629976T2 (de) 2004-07-22
EP0738735A2 (en) 1996-10-23
GB9507985D0 (en) 1995-06-07
US6090920A (en) 2000-07-18
NO961543L (no) 1996-10-21
US5895746A (en) 1999-04-20
JPH08291197A (ja) 1996-11-05

Similar Documents

Publication Publication Date Title
ES2013226A4 (es) Metodo y composiciones proveiendo quimicoluminiscencia mejorada de 1,2-dioxanos
DE69312513T2 (de) MENSCHLICHE CYCLOOXYGENASE-2cDNA UND BESTIMMUNG VON MENSCHLICHE CYCLOOXYGENASE-2-INHIBIERUNG
DK0564494T3 (da) Testmetode og reagenssæt dertil
NO961543L (no) Antistoff mot aminoterminalt propeptid av type 1 prokollagen og målemetode hvor det benyttes
IL129535A (en) Method of diagnosing bone dysbolism
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ATE142646T1 (de) Verfahren zur immunologischen bestimmung des carboxyterminalen peptids von typ-i-prokollagen
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
CA2075695A1 (en) Monoclonal antibodies to sulfonated polymers
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
DE58909219D1 (de) Einschritt-Immuntest zur Bestimmung von antigen-spezifischen Antikörpern aller Immunglobulin-Klassen und dazu geeignetes Mittel.
CA2081879A1 (en) Monoclonal antibodies to polyacrylate polymers
DE3863270D1 (de) Immuntest.
RU93015117A (ru) Способ определения "группы риска" рецидива лепры
ATE120009T1 (de) Verfahren zur quantitativen bestimmung von serumproteinen in körperflüssigkeiten und mittel zur durchführung des verfahrens.
JPS6488368A (en) Method for measuring complex of urokinase and urokinase inhibitor

Legal Events

Date Code Title Description
MK1K Patent expired